GL1X · GenesisL1 explorer

Ligand · 9MD

9MD · (2S)-2-[6-chloro-2-(4-chlorophenyl)-5-fluoro-1H-benzimidazol-1-yl]-N-cyclohexyl-2-[(2S)-oxan-2-yl]acetamide

9MD, (2S)-2-[6-chloro-2-(4-chlorophenyl)-5-fluoro-1H-benzimidazol-1-yl]-N-cyclohexyl-2-[(2S)-oxan-2-yl]acetamide (C26 H28 Cl2 F N3 O2, 504.4 g/mol), in the MolNFT structures on GenesisL1: bound in 1 record (1 PDB entry). Every binding site…

Component
9MD
Formula
C26 H28 Cl2 F N3 O2
Class
ligand
Structures
1
PDB entries
1

Binding sites

9MD in 1 structure; the first of them:

  • 5Q13 · Ligand binding to farnesoid-X-receptor · 9MD A501 · binds ILE273, ILE277, ASN287, ILE290, LEU291, MET294, ALA295, HIS298 and 16 more

Residues it binds most

ILE 2, MET 2, LEU 2, PHE 2, SER 2, ARG 2, HIS 2, ASN 2, TRP 2, TYR 2 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.